H1 2024 Life Sciences Update Market Summaries
Boston HUB MARKET
View H1 2024 Life Sciences Update
View All Markets
Market Summary • Greater Boston remains an increasingly dominant center of the life sciences industry, with a consistent international audience and an influx of scientists looking to contribute to the thriving environment. • The high concentration of R&D firms in Cambridge, particularly around Kendall Square, coupled with the region’s robust pool of life sciences talent due to its proximity to Harvard, MIT, and other world-renowned institutions, make it one of the most preeminent locations for life sciences activity in the world. • Greater Boston is home to top life sciences firms from around the world, including Takeda, Vertex, Biogen, Moderna and Foundation Medicine. • Year-to-date (YTD) construction completions were nearly double the project completions during the first half of 2023. More than 2.8 million square feet (msf) is still under construction and anticipated to deliver by year-end 2024. The total expected construction deliveries of 5.4 msf for 2024 will decline year-over-year (YOY), from 6.7 msf of deliveries in 2023. • New demand for both existing and new buildings slowed in the first half of 2024, totaling 450,833 sf of leasing activity, down 71% when compared to the first half of 2023. Of the 2.6 msf of construction deliveries in the first half of 2024, only 38% are currently leased. Projects that are delivered to the market mostly vacant have pushed the overall vacancy rate to its five-year high of 26.6%.
Public & Private Funding (2024 1H)
Rent vs. Vacancy Comparison
Fast Lab Stats
$15 $25 $35 $45 $55 $65 $75 $85 $95 $105
0% 3% 6% 9% 12% 15% 18% 21% 24% 27%
Company
Deal Type
Completed VC Round $ Raised (MM)
44.5 MSF Market Square Footage $90.39 $ Per SF 26.6% Vacancy 109.1K Total Life Sciences
Zenas BioPharma
Later Stage VC May 2024 4th Round $200.2 Later Stage VC Mar 2024 4th Round $181.9
Sionna
Vacancy Rate
Cerevance Later Stage VC Apr 2024 5th Round $163.0 Obsidian Therapeutics Later Stage VC Mar 2024 3rd Round $160.5 FogPharma Later Stage VC Feb 2024 5th Round $145.0 Keros Therapeutics (NAS: KROS) IPO Jan 2024 $140.0 Rapport Therapeutics (NAS: RAPP) IPO Jun 2024 $136.0 NextPoint Early Stage VC Feb 2024 3rd Round $122.5
Average Asking Rent $/sf
Fractyl Health (NAS: GUTS)
Employment 98.4% Life Sciences Employment 10-Year Growth Rate
2015 2017 2019 2021
2023
IPO
Feb 2024
$110.0
Asking Rents
Overall Vacancy
Sublease Vacancy
Inari
Later Stage VC Jan 2024 6th Round $103.0
Representative Investment Sale Transactions (2024 1H)
Address
Type
$/psf
$ MM $1.66 $1.66
RBA SF
Date
Buyer
Representative Life Sciences Companies
Life Sciences Labor: Average Monthly Job Postings and Hires
Office Office
300 Binney St 290 Binney St
$2,049.38 $2,049.38
240,000 March 2024 NBIM 570,000 March 2024 NBIM
Company Alnylam
Type
1,000 1,500 2,000 2,500 3,000
HQ HQ
Biogen
Bristol Myers Squibb
Regional HQ
Representative Lease Transactions (2024 1H)
Foundation Medicine HQ Moderna Tx HQ Novartis
Company
Address
City
Size (SF) New/Renewal
Type
Quarter Landlord/ Sublandlord
ADA Forsyth
Direct Direct
100 Chestnut Street Somerville
76,000 New Lease
Q1 Q1
North River Leerink
Regional HQ Regional HQ Regional HQ Regional HQ
0 500
BPG Bio
300 Third Avenue Waltham 70,000 New Lease
Lincoln Property Company
Pfizer Sanofi
Treeline Biosciences
500 Arsenal Street
Watertown 67,362 Renewal/Expansion Direct
Q2 Alexandria Real Estate Equities
2020 2021
2022
2023
2024
Tiax
35 Hartwell Avenue Lexington
46,700 Renewal
Direct Direct Direct Direct Direct
Q1 Q1 Q1 Q1 Q1 Q1
Anchor Line Partners Anchor Line Properties North River Company
Takeda Ph Vertex Ph
Hires Unique Postings
ANDE
266 Second Avenue Waltham 46,040 Renewal
HQ
Nest.Bio
100 Chestnut Street Somerville
41,000 New Lease
$2.7B Massachusetts General Hospital $1.7B Brigham and Women’s Hospital $1.0B Boston Children’s Hospital Top NIH-Funded Institutions (2020-2024 1H)
Bio Degree-Awarding Institutions, Metro Area • Boston University • University of Massachusetts Boston • Harvard University • MIT • Boston College • Northeastern University • Tufts University • Massachusetts College of Pharmacy and Health Sciences
Annual Life Sciences Degree Completions 2013 4,887
TScan Therapeutics
830 Winter Street
Waltham 25,472 New Lease Cambridge 25,000 Renewal
Morgan Stanley BioMed Realty
BioNTech
40 Erie Street
Nexo Tx & Aleksia Tx Incendia Therapeutics
500 Forge Street
Watertown Cambridge
21,251 New Lease 16,972 New Lease
Sublease
Boylston Properties
1 Canal Park
Direct
Q2 Breakthrough Properties
2023 7,015 Up 44%
Research Contributors Riley McMullan riley.mcmullan@cushwake.com
Nicole Salamone nicole.salamone@cushwake.com
Katie Mahoney kathleen.mahoney@cushwake.com
Sources: Cushman & Wakefield Research, CoStar, National Institutes of Health (NIH), Lightcast, Pitchbook
CUSHMAN & WAKEFIELD
LIFE SCIENCES UPDATE | 2024 FEBRUARY
Made with FlippingBook - Online magazine maker